Oshino Drugs Private Limited

Oshino Drugs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24239DL2000PTC103818 Incorporated 17 February 2000 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹15.75 Cr
▼ 15% YoY
Net profit · FY 2025
₹58.96 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹1.21 Cr
EBITDA margin 7.7%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹19.2 Lakh
Issued & subscribed
Open charges
₹1.22 Cr
Secured borrowings
Company age
26 yrs
Est. 2000
Employees · EPFO
2
Provident fund records

About Oshino Drugs Private Limited

Data last updated:

Oshino Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC103818. Its GSTIN is 09AAACO4958J1Z0 (Uttar Pradesh).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹19.2 Lakh. It is led by directors Vishal Gupta and Savita Rani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 240 Flat No. 107 1st Floor Pandav Nagar, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹15.75 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹58.96 Lakh (net margin 3.7%) and EBITDA of ₹1.21 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 14% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1.22 Cr on record. Court records list 5 cases involving the company, including 5 filed against it.

Oshino Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0020563). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239DL2000PTC103818
Registration Number 103818
Incorporation Date 17 February 2000
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-29-0020563

Recognitions & Rankings of Oshino Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UP-29-0020563

Contact details

Oshino Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C – 240 Flat No. 107 1st Floor Pandav Nagar, New Delhi, Delhi, India – 110092
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Oshino Drugs Private Limited, buy the company report.

Comprehensive company report
Oshino Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Oshino Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Oshino Drugs Private Limited, buy the company report.

Financials of Oshino Drugs Private Limited

FY 2025 filings available

Oshino Drugs Private Limited reported revenue of ₹15.75 Cr (down 15% YoY) for FY 2025.

Revenue · FY 2025
₹15.75 Cr ▼ 15%
Net profit · FY 2025
₹58.96 Lakh margin 3.7%
EBITDA · FY 2025
₹1.21 Cr margin 7.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 7%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 19%
5 years · compounded
▲ 4%

Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.21 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹58.96 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.7%
Net Profit Margin3.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Oshino Drugs Private Limited, buy the company report.

Board of directors of Oshino Drugs Private Limited

Oshino Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Savita RaniAdditional Director07 Jan 201016 Years 10 MonthsCurrent
Vishal GuptaDirector01 Oct 200521 Years 1 MonthsCurrent

Peer comparison

Oshino Drugs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Oshino Drugs Private Limitedthis company₹15.75 Cr (FY 2025)₹58.96 Lakh3.7%-15.0%2New Delhi, Delhi, India
Suma Pharmaceuticals Private Limited₹15.75 Cr (FY 2024)9.0%Ambernath, Maharashtra, India
Syntho Pharmaceuticals Private Limited₹15.7 Cr (FY 2025)-3.0%Uttar Pradesh, India
Hfa Formulations Private Limited₹15.65 Cr (FY 2024)42.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Oshino Drugs Private Limited, buy the company report.

Auditor

Oshino Drugs Private Limited is audited by M.C. GARG & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M.C. GARG & COFY 2023001251C

Shareholding

The shareholding of Oshino Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Oshino Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹0.80 Cr
Canara Bank₹0.42 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 May 2024100932764Canara Bank₹26.32 LakhOpen
15 Sep 2018100208785Canara Bank₹10 LakhOpen
31 Jan 201410496010Canara Bank₹5.65 LakhOpen
24 Sep 201010244272Others₹80 LakhOpen

To see the full charge records of Oshino Drugs Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Oshino Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Oshino Drugs Private Limited has a workforce of 2 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
2
Active EPFO establishments
1
Employee growth
100%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-272
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Oshino Drugs Private Limited, buy the company report.

GST

Oshino Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAACO4958J1Z0Uttar PradeshActive27 Jul 2017

To see the full GST registrations and return filing status of Oshino Drugs Private Limited, buy the company report.

Recent activity

Oshino Drugs Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Payal Gupta ceased to be Director on 07 Jan 2010.

AGM
Oshino Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oshino Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Canara Bank amounted to Rs. 26.32 Lakh with Charge ID 100932764 was registered on 18 May 2024.
Charges
A charge with Others of Rs. 80.00 Lakh registered on 24 Sep 2010 with Charge ID 10244272 was modified on 22 Dec 2021.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100208785 was registered on 15 Sep 2018.
Charges
A charge with Canara Bank amounted to Rs. 5.65 Lakh with Charge ID 10496010 was registered on 31 Jan 2014.
Charges
A charge with Others amounted to Rs. 80.00 Lakh with Charge ID 10244272 was registered on 24 Sep 2010.
Ceased
Payal Gupta ceased to be Director.
Appointed
Savita Rani was appointed as Additional Director.
Ceased
Rajesh Kumar Verma ceased to be Director.
Appointed
Vishal Gupta was appointed as Director.
Incorporation
17 Feb 2000
Oshino Drugs Private Limited was registered on 17 Feb 2000 with Roc Delhi & aged 26 years 9 months as per MCA records.

Frequently asked questions

Oshino Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2000 (26+ years old) and is registered under CIN U24239DL2000PTC103818.

Oshino Drugs has 2 current directors:

The latest financial statements of Oshino Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Oshino Drugs is 09AAACO4958J1Z0, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Oshino Drugs is U24239DL2000PTC103818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Oshino Drugs has 5 court cases on record: 5 filed against it. Most are in the high courts.

Oshino Drugs was incorporated on 17 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Oshino Drugs by revenue are Suma Pharmaceuticals Private Limited, Syntho Pharmaceuticals Private Limited, Hfa Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Payal Gupta ceased to be Director on 07 Jan 2010. Savita Rani was appointed as Additional Director on 07 Jan 2010. Rajesh Kumar Verma ceased to be Director on 06 Aug 2007. Oshino Drugs has 4 board changes on record in total.

Yes, Oshino Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-UP-29-0020563).

The registered office of Oshino Drugs is at C – 240 Flat No. 107 1st Floor Pandav Nagar, New Delhi, Delhi, India – 110092.